All Phenotypes Brca1<tm1Cxd> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Brca1^tm1Cxd
targeted mutation 1, Chu-Xia Deng
MGI:1930612

Summary

9 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Brca1^tm1Cxd/Brca1^tm1Cxd	either: 129S6/SvEvTac-Brca1^tm1Cxd or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6)	MGI:2174678
hm2	Brca1^tm1Cxd/Brca1^tm1Cxd	involves: 129S6/SvEvTac	MGI:6296798
cn3	Brca1^tm1Cxd/Brca1^tm2Cxd Trp53^tm1Brd/Trp53⁺ Tg(MMTV-cre)4Mam/0	involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB	MGI:2176786
cn4	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(Wap-cre)11738Mam/0	involves: 129S6/SvEvTac * Black Swiss	MGI:2176784
cn5	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(MMTV-cre)4Mam/0	involves: 129S6/SvEvTac * Black Swiss * FVB	MGI:2176785
cn6	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-cre)5132Jlj/0	involves: 129S6/SvEvTac * C57BL/6	MGI:2677031
cn7	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-cre)5132Jlj/0 Tg(KRT5-E2F1)2Dgj/0	involves: 129S6/SvEvTac * C57BL/6 * SJL	MGI:2677036
cx8	Brca1^tm1Cxd/Brca1^tm1Cxd Trp53^tm1Brd/Trp53^tm1Brd	involves: 129S6/SvEvTac * 129S7/SvEvBrd	MGI:3640093
cx9	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-E2F1)2Dgj/0	involves: 129S6/SvEvTac * C57BL/6 * SJL	MGI:2677035

Allelic Composition	Brca1^tm1Cxd/Brca1^tm1Cxd
Genetic Background	either: 129S6/SvEvTac-Brca1^tm1Cxd or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1^tm1Cxd mutation (1 available); any Brca1 mutation (114 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality between implantation and placentation, complete penetrance ( J:51834 )

• embryos die between E7.5-E9.5, achieving variable developmental stages

embryo

decreased embryo size ( J:51834 )

• at E7.5 and beyond, surviving embryos appear smaller than controls

abnormal embryonic tissue morphology ( J:51834 )

• at E6.5, embryos appear similar to controls

• at later stages, extraembryonic tissue appears normal while embryonic tissue appears smaller and disorganized

abnormal axial mesoderm morphology ( J:51834 )

abnormal primitive streak formation ( J:51834 )

• delayed at E9.5 in surviving embryos

cellular

abnormal chromosome number ( J:51834 )

• cells derived from E7.5 embryos exhibit widespread abnormalities in cell chromosome number; 30% of cells contain more or less than the normal complement of 40 chromosomes

increased cellular sensitivity to gamma-irradiation ( J:51834 )

• isolated blastocyts subjected to gamma-irradiation exhibited a reduction in the growth rate of trophoblast cells compared to controls

growth/size/body

decreased embryo size ( J:51834 )

• at E7.5 and beyond, surviving embryos appear smaller than controls

Allelic Composition	Brca1^tm1Cxd/Brca1^tm1Cxd
Genetic Background	involves: 129S6/SvEvTac

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1^tm1Cxd mutation (1 available); any Brca1 mutation (114 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cellular

abnormal double-strand DNA break repair ( J:269823 )

• impaired repair following radiation induced DNA damage in mouse embryonic fibroblast

homeostasis/metabolism

abnormal double-strand DNA break repair ( J:269823 )

• impaired repair following radiation induced DNA damage in mouse embryonic fibroblast

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Trp53^tm1Brd/Trp53⁺ Tg(MMTV-cre)4Mam/0
Genetic Background	involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1^tm1Cxd mutation (1 available); any Brca1 mutation (114 available)
Brca1^tm2Cxd mutation (3 available); any Brca1 mutation (114 available)
Tg(MMTV-cre)4Mam mutation (1 available)
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary gland tumor incidence ( J:54533 )

• by 6-8 months of age, 8 of 11 females developed mammary gland tumors that exhibited several distinct histopathologies

endocrine/exocrine glands

increased mammary gland tumor incidence ( J:54533 )

• by 6-8 months of age, 8 of 11 females developed mammary gland tumors that exhibited several distinct histopathologies

integument

increased mammary gland tumor incidence ( J:54533 )

• by 6-8 months of age, 8 of 11 females developed mammary gland tumors that exhibited several distinct histopathologies

Mouse Models of Human Disease	DO ID	OMIM ID(s)	Ref(s)
breast cancer	DOID:1612	OMIM:114480	J:54533
hereditary breast ovarian cancer syndrome	DOID:5683		J:54533

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(Wap-cre)11738Mam/0
Genetic Background	involves: 129S6/SvEvTac * Black Swiss

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

neoplasm

increased mammary gland tumor incidence ( J:54533 )

• 2 of 13 female mice developed mammary tumors of diverse types

endocrine/exocrine glands

abnormal mammary gland development ( J:54533 )

• developmental defects may correlate with apoptosis observed in mutant mammary glands

abnormal branching of the mammary ductal tree ( J:54533 )

• abnormal ductal morphogenesis was observed at lactation and involution

abnormal involution of the mammary gland ( J:54533 )

• residual alveolar structures sometimes remain in involuting mammary glands

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

increased mammary gland tumor incidence ( J:54533 )

• 2 of 13 female mice developed mammary tumors of diverse types

integument

abnormal mammary gland development ( J:54533 )

• developmental defects may correlate with apoptosis observed in mutant mammary glands

abnormal branching of the mammary ductal tree ( J:54533 )

• abnormal ductal morphogenesis was observed at lactation and involution

abnormal involution of the mammary gland ( J:54533 )

• residual alveolar structures sometimes remain in involuting mammary glands

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

increased mammary gland tumor incidence ( J:54533 )

• 2 of 13 female mice developed mammary tumors of diverse types

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(MMTV-cre)4Mam/0
Genetic Background	involves: 129S6/SvEvTac * Black Swiss * FVB

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

neoplasm

increased mammary gland tumor incidence ( J:54533 )

• 3 of 10 female mice developed mammary tumors of diverse types

increased mammary adenocarcinoma incidence ( J:54533 )

endocrine/exocrine glands

abnormal mammary gland development ( J:54533 )

• developmental defects may correlate with apoptosis observed in mutant mammary glands

abnormal branching of the mammary ductal tree ( J:54533 )

• abnormal ductal morphogenesis was observed at lactation and involution

abnormal involution of the mammary gland ( J:54533 )

• residual alveolar structures sometimes remain in involuting mammary glands

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

increased mammary gland tumor incidence ( J:54533 )

• 3 of 10 female mice developed mammary tumors of diverse types

increased mammary adenocarcinoma incidence ( J:54533 )

integument

abnormal mammary gland development ( J:54533 )

• developmental defects may correlate with apoptosis observed in mutant mammary glands

abnormal branching of the mammary ductal tree ( J:54533 )

• abnormal ductal morphogenesis was observed at lactation and involution

abnormal involution of the mammary gland ( J:54533 )

• residual alveolar structures sometimes remain in involuting mammary glands

abnormal mammary gland growth during pregnancy ( J:54533 )

• at pregnancy day 8.5, mammary glands are smaller than controls

• at pregnancy day 16.5, mammary development is incomplete with fat pads that are less than 80% filled in the most severely affected mutants

increased mammary gland tumor incidence ( J:54533 )

• 3 of 10 female mice developed mammary tumors of diverse types

increased mammary adenocarcinoma incidence ( J:54533 )

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-cre)5132Jlj/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:85354 )

• develop tumors in the skin, inner ear canal, and oral epithelium after 1 year of age, such that at 70 weeks of age, 42.9% and by 88 weeks of age, 72% of mice have tumors

increased mouth tumor incidence ( J:85354 )

• develop tumors in the oral epithelium

increased skin tumor incidence ( J:85354 )

• develop tumors in the skin

increased squamous cell carcinoma incidence ( J:85354 )

• majority of tumors are squamous cell carcinomas of the inner ear canal and oral epithelium

integument

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

abnormal epidermal layer morphology ( J:85354 )

• mutants exhibit increased epidermal proliferation and apoptosis, however epidermis appears histologically normal

increased skin tumor incidence ( J:85354 )

• develop tumors in the skin

cellular

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

digestive/alimentary system

increased mouth tumor incidence ( J:85354 )

• develop tumors in the oral epithelium

craniofacial

increased mouth tumor incidence ( J:85354 )

• develop tumors in the oral epithelium

growth/size/body

increased mouth tumor incidence ( J:85354 )

• develop tumors in the oral epithelium

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-cre)5132Jlj/0 Tg(KRT5-E2F1)2Dgj/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1^tm1Cxd mutation (1 available); any Brca1 mutation (114 available)
Brca1^tm2Cxd mutation (3 available); any Brca1 mutation (114 available)
Tg(KRT5-cre)5132Jlj mutation (1 available)
Tg(KRT5-E2F1)2Dgj mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

preweaning lethality, incomplete penetrance ( J:85354 )

• fewer (6.25%) than the expected 12.5% of mutants were observed, indicating some lethality; time of analysis not specified

neoplasm

increased skin tumor incidence ( J:85354 )

• by 45 weeks of age, all mutants develop at least one skin tumor, with an average of four tumors per mouse

increased squamous cell carcinoma incidence ( J:85354 )

• skin tumors are all squamous cell carcinoma

decreased tumor latency ( J:85354 )

• all mutants develop tumors by 45 weeks of age, significantly sooner than Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-cre)1Jlj/0 mice or Brca1^tm2Cxd/Brca1⁺ Tg(KRT5-cre)1Jlj/0 mice and by 70 weeks of age, 100% of mice exhibit tumors

integument

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

abnormal epidermal layer morphology ( J:85354 )

• mutants exhibit increased epidermal proliferation and apoptosis

increased skin tumor incidence ( J:85354 )

• by 45 weeks of age, all mutants develop at least one skin tumor, with an average of four tumors per mouse

cellular

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

Allelic Composition	Brca1^tm1Cxd/Brca1^tm1Cxd Trp53^tm1Brd/Trp53^tm1Brd
Genetic Background	involves: 129S6/SvEvTac * 129S7/SvEvBrd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1^tm1Cxd mutation (1 available); any Brca1 mutation (114 available)
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:51834 )

• double mutant embryos survive on average of 2 days longer than Brca1^tm1Cxd single homozygous embryos

• at E10.5, all double homozygous embryos are dead or dying

embryo

decreased embryo size ( J:51834 )

abnormal embryonic tissue morphology ( J:51834 )

• morphologically abnormal compared to controls

cellular

abnormal chromosome number ( J:51834 )

• 29% of cells contained more than 40 chromosomes and 43% of cells contained less than 40 chromosomes

spontaneous chromosome breakage ( J:51834 )

• many cells show chromosomal rearrangements such as translocations and dicentric chromosomes

growth/size/body

decreased embryo size ( J:51834 )

Allelic Composition	Brca1^tm1Cxd/Brca1^tm2Cxd Tg(KRT5-E2F1)2Dgj/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * SJL

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:85354 )

• 94.7% of mutants develop tumors at 70 weeks of age

increased mouth tumor incidence ( J:85354 )

• some females develop tumors in the oral epithelium

increased skin tumor incidence ( J:85354 )

• develop tumors in the skin

increased squamous cell carcinoma incidence ( J:85354 )

• females develop squamous cell carcinoma in the cervix and vaginal epithelium

increased papilloma incidence ( J:85354 )

• females develop papillomas in the cervix

increased reproductive system tumor incidence ( J:85354 )

• develop tumors of the reproductive tract; all females develop tumors, with the majority from the cervix (papillomas and squamous cell carcinoma) and vaginal epithelium (squamous cell carcinoma)

integument

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

abnormal epidermal layer morphology ( J:85354 )

• mutants exhibit increased epidermal proliferation and apoptosis

increased skin tumor incidence ( J:85354 )

• develop tumors in the skin

cellular

increased keratinocyte proliferation ( J:85354 )

• increase in basal keratinocyte proliferation

reproductive system

increased reproductive system tumor incidence ( J:85354 )

• develop tumors of the reproductive tract; all females develop tumors, with the majority from the cervix (papillomas and squamous cell carcinoma) and vaginal epithelium (squamous cell carcinoma)

digestive/alimentary system

increased mouth tumor incidence ( J:85354 )

• some females develop tumors in the oral epithelium

craniofacial

increased mouth tumor incidence ( J:85354 )

• some females develop tumors in the oral epithelium

growth/size/body

increased mouth tumor incidence ( J:85354 )

• some females develop tumors in the oral epithelium

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24